Rapilif (Rapaflo)4 Mg – 150 tablet

Name: Rapilif (Rapaflo)4 Mg - 150 tablet
SKU: 75b4f6aa7912
Availability: OutOfStock

USD $100.20

Each Rapilif contains 4 mg Silodosin 100 tablets. Used to treat the signs and symptoms of benign prostatic hyperplasia (prostate enlargement).

ATC Classification: G04CA04
Active Ingrediant: Silodosin
Generic Name: Rapilif
Manufacturer: IPCA Lab Ltd
Strength: 4 Mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 Tabs

Out of stock

Ipca Lab

Medication Safety Issues

Sound-alike/look-alike issues:

Rapaflo may be confused with Rapamune

Silodosin may be confused with sildenafil, sirolimus

Storage/Stability

Store at room temperature of 25?C (77?F); excursions permitted to 15?C to 30?C (59?F to 86?F). Protect from light. Protect from moisture.

Adverse Reactions

>10%: Genitourinary: Retrograde ejaculation (28%)

1% to 10%:

Cardiovascular: Orthostatic hypotension (3%; increased in elderly ?65 years up to 5%)

Central nervous system: Dizziness (3%), headache (2%), insomnia (1% to 2%)

Gastrointestinal: Diarrhea (3%), abdominal pain (1% to 2%)

Genitourinary: Prostate specific antigen increased (1% to 2%)

Neuromuscular & skeletal: Weakness (1% to 2%)

Respiratory: Nasal congestion (2%), rhinorrhea (1% to 2%), sinusitis (1% to 2%)

<1%, postmarketing, and/or case reports: Hepatic insufficiency, hypersensitivity reaction, increased serum transaminases, intraoperative floppy iris syndrome, jaundice, pharyngeal edema, priapism, pruritus, purpura, skin rash (including toxic), swollen tongue, syncope, urticaria